This study is testing an experimental antibody called PRL3-Zumab in people with advanced solid tumors that cannot be surgically removed or have spread. The goal is to see if the treatment is safe and can help control the cancer by measuring how long patients live without their di…
Phase: PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC